Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
0.655
-0.010 (-1.50%)
Jan 17, 2025, 4:00 PM EST - Market closed
Enzo Biochem Revenue
Enzo Biochem had revenue of $6.21M in the quarter ending October 31, 2024, a decrease of -20.41%. This brings the company's revenue in the last twelve months to $30.31M, down -4.56% year-over-year. In the fiscal year ending July 31, 2024, Enzo Biochem had annual revenue of $31.91M with 2.72% growth.
Revenue (ttm)
$30.31M
Revenue Growth
-4.56%
P/S Ratio
1.11
Revenue / Employee
$222,897
Employees
136
Market Cap
34.22M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 31.91M | 846.00K | 2.72% |
Jul 31, 2023 | 31.06M | -1.58M | -4.85% |
Jul 31, 2022 | 32.64M | -85.09M | -72.27% |
Jul 31, 2021 | 117.73M | 41.71M | 54.87% |
Jul 31, 2020 | 76.02M | -5.15M | -6.34% |
Jul 31, 2019 | Pro | Pro | Pro |
Jul 31, 2018 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Jul 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
ENZ News
- 6 days ago - Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules - GlobeNewsWire
- 5 weeks ago - Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update - GlobeNewsWire
- 2 months ago - Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend - GlobeNewsWire
- 5 months ago - Enzo Biochem to pay $4.5 mln for failing to safeguard patient data - Reuters
- 6 months ago - Enzo Biochem: Is This Time Finally Different? - Seeking Alpha
- 7 months ago - Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire
- 11 months ago - Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire
- 1 year ago - Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments - GlobeNewsWire